Value investing message boards image Log on |  Join ($$) Stock market forums image VF "How To" Guide        Welcome, guest! Learn about guest access               Home
• Related Discussion Forum Messages
As a ValueForum member, this section would contain JNJ message board posts where the ticker symbol JNJ has been mentioned by ValueForum members in posts. Learn more about guest access, and benefits of membership -- we hope you will consider joining ValueForum or trying out our service with a 24 hour trial pass.

• Latest JNJ SEC Filings

Filings Format Description Filing Date File/Film Number
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001225208-18-006206 Size: 4 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001225208-18-006205 Size: 5 KB
DEFA14A  Documents Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Acc-no: 0000200406-18-000010 (34 Act)  Size: 133 KB
2018-03-14 001-03215
DEF 14A  Documents Other definitive proxy statements
Acc-no: 0000200406-18-000009 (34 Act)  Size: 5 MB
2018-03-14 001-03215
10-K  Documents   Interactive Data Annual report [Section 13 and 15(d), not S-K Item 405]
Acc-no: 0000200406-18-000005 (34 Act)  Size: 19 MB
2018-02-21 001-03215
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001225208-18-003484 Size: 8 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001225208-18-003075 Size: 4 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001225208-18-003074 Size: 5 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001225208-18-003073 Size: 5 KB
4  Documents Statement of changes in beneficial ownership of securities
Acc-no: 0001225208-18-003072 Size: 4 KB
More JNJ SEC Filings

Related news from
Fri, 16 Mar 2018
19:40:05 +0000
Dow Stocks Lead As Walmart, AmEx Rise But GE And Apple Sit Out
Key market index funds were mixed Friday as SPDR Dow Jones industrial average rose but the tech-heavy QQQs slipped.
Fri, 16 Mar 2018
16:15:17 +0000
Johnson & Johnson nears diabetes device exit with $2.1 billion LifeScan sale
Platinum has given J&J until mid-June to accept the offer to allow for consultations with overseas workers. Sales at J&J's diabetes device business, which also includes Animas Corp and Calibra Medical Inc, have been falling since 2012 in a highly competitive market and the company said last January that it was evaluating options for the units.
Fri, 16 Mar 2018
14:46:02 +0000
Pharma Stock Roundup: ABBV's Elagolix Meets Study Goal, MRK's Keytruda in Focus
Merck gains priority review for Keytruda in advanced cervical cancer, AbbVie's elagolix meets primary endpoint in second phase III study.
Fri, 16 Mar 2018
14:32:00 +0000
Will These Management Changes Drive Dentsply Sirona toward a New Growth Trajectory?
Starting in October 2017, Dentsply Sirona (XRAY) implemented a series of management changes with the aim of positioning the company as a stronger and more efficient organization and maintaining the company’s leadership position in dentistry. In October, the company accepted the resignations of Executive Chairman Bret W. Wise, CEO and Director Jeffrey T. Slovin, and President and COO (chief operating officer) Christopher T. Clark. Mark A. Thierer was appointed interim CEO, and Bob Size was appointed interim president and COO. Mark A. Thierer has around 30 years of healthcare industry experience and most recently served as the CEO of OptumRx.
Fri, 16 Mar 2018
13:02:38 +0000
A Closer Look at Pfizer’s 4Q17 Growth Drivers
An Overview of Pfizer's 4Q17: What Lies Ahead?
Fri, 16 Mar 2018
12:22:02 +0000
[$$] J&J Gets $2.1 Billion Offer for Blood Glucose Monitoring Business
Johnson & Johnson received a $2.1 billion binding offer for its blood glucose monitoring business from private-equity firm Platinum Equity.
Fri, 16 Mar 2018
12:04:11 +0000
J&J says offered $2.1 bln for Lifescan diabetes business
Johnson & Johnson said on Friday that private investment firm Platinum Equity had offered to buy its LifeScan Inc diabetes care business for about $2.1 billion. LifeScan makes blood glucose monitoring products and generated net revenue of about $1.5 billion in 2017, Johnson & Johnson said.
Fri, 16 Mar 2018
12:00:45 +0000
See what the IHS Markit Score report has to say about Johnson & Johnson.
Johnson & Johnson NYSE:JNJ
Fri, 16 Mar 2018
11:59:00 +0000
J&J says it's received a $2.1 billion bid for LifeScan diabetes business
The offer to Johnson & Johnson for LifeScan is from private equity firm Platinum Equity.
Fri, 16 Mar 2018
11:56:03 +0000
J&J Reaches $2.1 Billion Deal to Sell Diabetes Device Business
Johnson & Johnson got a $2.1 billion offer from a private-equity firm for its glucose monitor business LifeScan, the drugmaker said Friday.
Fri, 16 Mar 2018
11:53:00 +0000
Stocks making the biggest moves premarket: TIF, JNJ, ADBE, ULTA, WMT, NKE & more
These are the stocks posting the largest moves before the bell.
Fri, 16 Mar 2018
11:39:11 +0000
Johnson & Johnson says Platinum Equity has offered to buy LifeScan for $2.1 billion
Johnson & Johnson said Friday it has received a binding offer from Platinum Equity to acquire its LifeScan business for about $2.1 billion. LifeScan is a blood glucose monitoring system with 2017 revenue ...
Fri, 16 Mar 2018
11:33:24 +0000
Platinum Equity Submits Binding Offer to Acquire LifeScan From Johnson & Johnson
LOS ANGELES, March 16, 2018-- Platinum Equity announced today that it has submitted a binding offer to acquire LifeScan, Inc. from Johnson & Johnson in a transaction valued at approximately $2.1 billion. ...
Fri, 16 Mar 2018
11:30:00 +0000
Johnson & Johnson Announces Binding Offer from Platinum Equity to Acquire LifeScan, Inc.
NEW BRUNSWICK, New Jersey, March 16, 2018 /PRNewswire/ -- Johnson & Johnson (JNJ) today announced that it has received a binding offer from Platinum Equity, a leading private investment firm, to acquire its LifeScan business for approximately $2.1 billion, subject to customary adjustments. LifeScan, Inc. is a leader in blood glucose monitoring products with 2017 net revenue of approximately $1.5 billion. "LifeScan's OneTouch® blood glucose monitoring products play an important role in the lives of millions of patients living with diabetes, and following a thorough review of all strategic options, we feel confident that the business would have a promising future with Platinum Equity," said Ashley McEvoy, Company Group Chairman, Consumer Medical Devices, Johnson & Johnson.
Fri, 16 Mar 2018
11:11:11 +0000
J&J's (JNJ) Erdafitinib Gets Breakthrough Therapy Status
The breakthrough therapy designation for J&J's (JNJ) erdafitinib was based on efficacy findings from a phase II study, evaluating it in advanced urothelial cancer.
Thu, 15 Mar 2018
19:44:00 +0000
Why Google co-founder Sergey Brin was using a robot to put sutures in synthetic tissue
Alphabet and J&J have a company called Verb Surgical that is aiming to bring its surgical robots to the market by 2020.
Thu, 15 Mar 2018
15:47:21 +0000
Here's Why Shorting Geron Corporation Stock Is a Terrible Idea
Short-sellers may want to exit this tiny biotech soon.

"ValueForum is an active, private, online discussion community for stock & bond market investing. In discussion forums divided into finely grained topics, you will find sophisticated investors trading tips, research, and due diligence on value stocks, income investments, forex, market news, and more. Join in - trade ideas, strategies, current news, via our unique message bulletin boards, stock ratings system, and other online tools specifically geared toward our community."

Random member testimonial: "I have been a VF subscriber for one year and have found the members here generally to be informed, intelligent, articulate people of good will. The knowledge I've gathered has been well worth the price of tuition, and the subscription fee has been repaid many-fold in investment gains." more testimonials »

Email / About | Privacy | Terms of Use | How To / FAQ | Msg Ticker | VF Home | My.vf | BDCs.vf | Energy.vf | REITs.vf | TA.vf
Nothing in is intended to be investment advice, nor does it represent the opinion of, counsel
from, or recommendations by ©2003 - 2018, Powered in part by Ticker TechnologiesContact Us

Stock Market Investing Forum - Trading Tips & Research - Online Message Boards